Vertex, Incyte fall; Precigen, Magnachip rise

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:

Vertex Pharmaceuticals Inc., down $23.75 to $193.02.

The biotechnology company ended development of a potential treatment for a genetic condition that targets the liver.

Dave & Buster's Entertainment Inc., down $1.21 to $42.87.

Investors remained cautious about the beaten down restaurant and arcade owner, despite reporting surprisingly good first-quarter earnings.

Incyte Corp., down $4.95 to $82.58.

The biotechnology company's potential eczema cream ruxolitinib faces a delayed regulatory review.

Precigen Inc., up 34 cents to $7.33.

The biotechnology company gave investors an encouraging development update for a potential diabetes treatment.

Magnachip Semiconductor Corp., up $2.86 to $25.91.

The chipmaker, which agreed to a buyout from South Dearborn, received a bigger offer from Cornucopia Investment Partners.

Royal Caribbean Group, down 54 cents to $90.09.

The cruise line operator said two guests sharing a stateroom onboard its Celebrity Millennium tested positive for COVID-19.

MKS Instruments Inc., down $3.78 to $177.56.

The maker of analysis and processing equipment for semiconductor companies is reportedly seeking to buy Atotech.

Western Digital Corp., up $1.22 to $74.78.

The maker of hard drives for businesses and personal computers gave investors an encouraging update during a business conference.

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Should you invest $1,000 in Magnachip Semiconductor right now?

Before you consider Magnachip Semiconductor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Magnachip Semiconductor wasn't on the list.

While Magnachip Semiconductor currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
MKS Instruments (MKSI)
3.8199 of 5 stars
$120.75+3.9%0.73%-4.38Moderate Buy$128.75
Vertex Pharmaceuticals (VRTX)
4.2722 of 5 stars
$397.48-0.1%N/A28.62Hold$429.45
Incyte (INCY)
4.8137 of 5 stars
$51.68+1.0%N/A19.50Hold$75.50
Magnachip Semiconductor (MX)
3.4252 of 5 stars
$5.00+4.6%N/A-5.75Buy$10.00
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: